# Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions

> **NCT01186120** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 500 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Biolimus A9-eluting stent
- **DEVICE:** Everolimus-eluting stent

## Key facts

- **NCT ID:** NCT01186120
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-05
- **Final completion:** 2013-08
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2013-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186120, "Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01186120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*